However, no difference on survival times was found when compared GBM cases with upregulated and downregulated STMN1 (Breslow = 0.092, median survival time at 11 and 13 months, respectively) and for MELK (log rank: 0.745). The gene discussed is MELK; the disease is glioblastoma.